Nearly every person with Down syndrome eventually develops Alzheimer’s disease, yet people with the syndrome routinely are excluded from Alzheimer’s clinical trials, as the cognitive assessment tools designed for the general population often are inappropriate for people with developmental disabilities. Consequently, nobody knows whether the new Alzheimer’s therapeutics hitting the market will work for people […]
In efforts to identify who is at risk of developing Alzheimer’s dementia, researchers over the years have zeroed in on several signs — or biological markers — that indicate early stages of the disease. If individuals could be identified long before symptoms of dementia begin to appear, doctors could target those patients with future preventive […]
At the Washington University in St. Louis Board of Trustees meeting Oct. 4, more than a dozen faculty members were appointed or promoted with tenure or granted tenure, effective Oct. 4 unless otherwise indicated. Appointment with tenure Flora Cassen as associate professor of Jewish, Islamic and Middle Eastern studies and of history in Arts & Sciences; […]
Jason Hassenstab, assistant professor of neurology at the School of Medicine, has received a $3.4 million grant from the National Institutes of Health (NIH)‘s National Institute on Aging to develop a smartphone app to assess cognition in people at risk of developing Alzheimer’s disease. Read more.